Bruce Mitlak

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Robert M. Neer, Claude D. Arnaud, José Zanchetta et al. · New England Journal of Medicine · 2001 · 4.5K citations

Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

Pierre D. Delmas, Nina H. Bjarnason, Bruce Mitlak et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

Yebin Jiang, Jenny Zhao, Bruce Mitlak et al. · Journal of Bone and Mineral Research · 2003 · 624 citations

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

Per Aspenberg, Harry K. Genant, Torsten Johansson et al. · Journal of Bone and Mineral Research · 2009 · 504 citations · Full text

Skeletal Trauma, Animal Experiments, Bone Disease +14

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Somnath Sarkar, Bruce Mitlak, Mayme Wong et al. · Journal of Bone and Mineral Research · 2002 · 449 citations · Full text